ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Commentary.

Daniel Gratch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.